Impala vs Sleepiz One+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Impala

by AliveCor

Sleepiz One+

by Sleepiz

AI Verdict

Impala is an AI-powered, portable 12-Lead ECG device for healthcare professionals, designed for rapid cardiac assessment and detection of life-threatening cardiac conditions, including heart attacks. Sleepiz One+ is a contactless remote patient monitoring device that collects biometric data and records vital signs like respiration and heart rate from a patient's bedside, primarily for long-term monitoring of chronic conditions and sleep apnea screening. While both utilize AI and focus on cardiac and respiratory health, Impala is an acute diagnostic tool for ECGs, whereas Sleepiz One+ is a passive, continuous monitoring solution for broader vital signs and sleep patterns.

Choose Impala if…

Choose Impala if you are a healthcare professional needing a portable, AI-powered 12-Lead ECG for rapid and accurate cardiac assessment, especially for detecting life-threatening conditions like heart attacks. Its reduced leadset and AI technology (KAI™ 12L) streamline the acquisition and interpretation of ECGs, making it ideal for emergency medicine and cardiology specialists.

View Impala →

Choose Sleepiz One+ if…

Choose Sleepiz One+ if you require contactless remote patient monitoring for chronic conditions, particularly in geriatrics, pulmonology, or sleep medicine. This device excels at continuously measuring respiration rate and heart rate from a patient's bedside, offering a non-invasive solution for sleep apnea screening and early detection of physiological changes without the need for wearables.

View Sleepiz One+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Impala	Sleepiz One+
Pricing	Contact for pricing	Contact for pricing
Deployment	Portable device, integrated with mobile applications/platforms.	Wall-mounted or bedside table placement, Wi-Fi connectivity
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Sleepiz One+

Sleepiz One+ offers contactless monitoring, which generally translates to higher patient comfort and ease of use compared to a device requiring electrode placement. While Impala has a reduced leadset, it still requires physical application, which can be a barrier for some users or in certain clinical scenarios.

Clinical Value

Impala

Impala provides a 12-Lead ECG, including AI-powered cardiac determinations for detecting life-threatening conditions like heart attacks, offering a more direct and critical diagnostic capability for acute cardiac events. Sleepiz One+ focuses on continuous vital sign monitoring and sleep apnea screening, which is valuable for chronic condition management but less about acute, life-threatening diagnoses.

Pricing & Value

Tie

Both tools require contacting the company for pricing, making a direct comparison of cost-effectiveness difficult. However, Sleepiz One+ highlights CPT codes for reimbursement, which could offer a clearer path to financial viability for providers. Impala's value is in its diagnostic capability, which could also lead to cost savings by enabling faster, more accurate diagnoses.

Enterprise Readiness

Tie

Both tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), indicating a strong foundation for enterprise adoption. Their deployment methods (portable with mobile integration for Impala, wall-mounted/bedside with Wi-Fi for Sleepiz One+) suggest they can be integrated into various healthcare settings.

Innovation

Tie

Both tools demonstrate significant innovation in their respective fields. Impala's AI-powered 12-Lead ECG with a reduced leadset for rapid assessment is innovative for cardiac diagnostics. Sleepiz One+'s contactless radar technology for continuous vital sign monitoring and sleep apnea screening is also a novel approach to remote patient monitoring.

Support & Docs

Tie

The provided information does not include details about the specific support and documentation offered by either company. Without this information, it is not possible to definitively determine a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Impala	Sleepiz One+
Name	Impala	Sleepiz One+
Company	AliveCor	Sleepiz
Description	AliveCor's 'Impala' (FDA K232035) is a portable, AI-powered 12-Lead ECG device for healthcare professionals, not a physician directory tool. AliveCor specializes in cardiac monitoring solutions.	Sleepiz One+ is an FDA-cleared contactless remote patient monitoring device that collects biometric data and records vital signs from a patient's bedside, providing comprehensive respiration and heart rate monitoring for chronic conditions.
Tagline	Transforming cardiology with AI-powered, portable ECG solutions.	Contactless Monitoring for Senior Care
Categories	Cardiology AI, Clinical Decision Support & Reference	Cardiology AI, Wearables & Remote Monitoring (RPM)
Key Features	Portable 12-Lead ECG acquisition, Acquires 4 standard diagnostic-bandwidth leads (I, II, V1 or V2, V4), Derives 4 standard diagnostic-bandwidth leads (aVL, aVR, aVF, III), Software generates remaining leads (V2 or V1, V3, V5, V6) for 12-Lead recording, AI technology (KAIu2122 12L) for cardiac determinations, Detects life-threatening cardiac conditions, including heart attacks, Reduced leadset for easier placement (single cable with 5 electrodes for 8 diagnostic-quality leads), Designed for rapid cardiac assessment	Contactless monitoring (radar technology), Measures respiration rate, Measures heart rate, Sleep apnea screening, Remote patient monitoring, AI-powered data analysis, Web application for data access and analysis, Easy setup and deployment

Videos

Demos, reviews, and walkthroughs featuring Impala and Sleepiz One+.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

Impala is designed for rapid 12-Lead ECG acquisition in clinical and acute settings, aiming to streamline the process compared to traditional ECGs. AliveCor offers EHR integration to automatically pull ECGs into systems like GE Healthcare's MUSEu2122 NX, and provides an SDK and API for developers to integrate ECG data into their own applications. Sleepiz One+ is a contactless remote patient monitoring device that transmits data securely to cloud servers, which can then be accessed via a web interface and pushed to clinicians for analysis. Sleepiz also offers flexible data access for investigators and sponsors to review overnight vital sign recordings in their web application or integrate directly into existing systems.

What is the accuracy and sensitivity of each tool for detecting relevant clinical conditions?

Impala, powered by AliveCor's KAIu2122 12L AI, is designed to detect 35 cardiac determinations, including life-threatening conditions like heart attacks, using a reduced lead set. Studies have shown that the Kardia 12L ECG System performs comparably to a standard 12-lead ECG in detecting major morphological cardiac abnormalities, including bundle branch blocks, ischemia, and myocardial infarction. Sleepiz One+ has demonstrated 99% accuracy in breathing rate and 96% accuracy in heart rate measurements compared to gold-standard methods. For sleep apnea screening, Sleepiz One+ showed a sensitivity of 85% and specificity of 88% for detecting moderate to severe OSA without additional SpO2, which increased to 88% sensitivity and 98% specificity with an added SpO2 sensor.

What is the learning curve for physicians and support staff, and what kind of support is available?

Impala is designed with a one-cable design and five lead placements to reduce logistical hurdles and learning curves associated with traditional 12-lead ECGs, allowing qualified personnel with infrequent ECG experience to acquire a high-quality recording in minutes. AliveCor offers personalized support through its AI-powered AskKardia virtual assistant for instant guidance and customer support. Sleepiz One+ is designed for easy setup and deployment, with a participant setup time of less than 3 minutes. Users have found the device easy to install, and data transmission is automatically ensured through a cellular module. Support resources include a setup guide to address common placement mistakes.

Are there customer references or case studies available to demonstrate real-world effectiveness and multi-site rollout considerations?

AliveCor has over 250 million ECGs recorded and their Kardia devices are clinically validated. They offer case studies, such as a fully decentralized Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Phase II trial, and highlight their experience powering millions of ECGs in clinical trials. Sleepiz has facilitated a large number of long-term studies with over 6 months of monitoring and has partnerships with companies like Bayer and Clario for clinical trials. Sleepiz One+ has seen growing adoption in the US and recently expanded into India, Australia, and New Zealand, with European regulatory reviews underway, and has been adopted by more than 250 practices.

What is the typical time-to-value for implementing these tools in a clinical practice or multi-site healthcare system?

Impala aims to provide rapid ECG diagnosis in clinical practice, with its simplified design assisting healthcare providers in rapid disease detection. The portable nature and reduced leadset of Impala are designed to reduce time and logistical hurdles compared to traditional 12-lead ECGs. Sleepiz One+ is designed for easy setup, with a participant setup time of less than 3 minutes, and offers automatic cellular data transmission, suggesting a quick deployment and data collection process. Sleepiz also highlights that their solution can save costs compared to traditional polysomnography and in-clinic vital sign measurements.

In what clinical contexts would each tool be most beneficial, considering their specialized features?

Impala is ideal for cardiology and emergency medicine, particularly for rapid cardiac assessment and detecting life-threatening cardiac conditions, including heart attacks, in settings where traditional 12-lead ECGs are not practical. Its portability and AI-powered analysis make it suitable for primary care offices, urgent care clinics, and remote locations. Sleepiz One+ is best suited for geriatrics, pulmonology, and sleep medicine, offering contactless remote patient monitoring of respiration and heart rate, and sleep apnea screening. It is particularly beneficial for long-term monitoring of chronic conditions, in-home use, and for immobile or infectious patients, as it provides continuous, unobtrusive data collection.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Impala or Sleepiz One+

Backers

Who funded each tool's parent company.

Impala

Sleepiz One+

Poli Angels